AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33471548 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal boost arm
Number of subjects: 571
Study 33471548 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment arm
Number of subjects: 571
Study 33471548 — intervention group
Group type: COMPARATOR
Intervention: Standard arm
Number of subjects: 571
Study 33471548 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal boost arm and Standard arm
Number of subjects: 571
Study 36213585 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 272
Study 36213585 — intervention group
Group type: COMPARATOR
Intervention: Traditional open surgery
Number of subjects: 272
Study 34407771 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intervention
Number of subjects: 103
Study 34407771 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 103
Study 34407771 — intervention group
Group type: COMPARATOR
Intervention: Digital intervention and Treatment as usual
Number of subjects: 103
Study 34704605 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural Network (NN)
Number of subjects: 17793
Study 34704605 — intervention group
Group type: COMPARATOR
Intervention: Logistic Regression (LR)
Number of subjects: 17793
Study 32192275 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3 mg intravenously) combined with Aprepitant (125 mg orally, D1 and 80 mg orally, D2-3) and Dexamethasone (12 mg orally or intravenously, D1 and 8 mg orally, D2-4)
Number of subjects: 279
Study 32192275 — intervention group
Group type: COMPARATOR
Intervention: Palonosetron (0.25 mg intravenously) combined with Aprepitant (125 mg orally, D1 and 80 mg orally, D2-3) and Dexamethasone (12 mg orally or intravenously, D1 and 8 mg orally, D2-4)
Number of subjects: 279
Study 32192275 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron (RAD)
Number of subjects: 279
Study 32192275 — intervention group
Group type: COMPARATOR
Intervention: Palonosetron (PAD)
Number of subjects: 279
Study 35296183 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise for 48 weeks
Number of subjects: 84
Study 35296183 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 84
Study 35296183 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise
Number of subjects: 84
Study 33419188 — intervention group
Group type: EXPERIMENTAL
Intervention: TNT (CRT followed by three cycles of CAPOX)
Number of subjects: 197
Study 33419188 — intervention group
Group type: COMPARATOR
Intervention: CRT (50 Gy with oral capecitabine)
Number of subjects: 197
Study 32342143 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted PAO
Number of subjects: 91
Study 32342143 — intervention group
Group type: COMPARATOR
Intervention: Conventional PAO
Number of subjects: 91
Study 35612708 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone 20 mg with high-fat, high-calorie meal
Number of subjects: 81
Study 35612708 — intervention group
Group type: COMPARATOR
Intervention: Finerenone 10 mg with omeprazole
Number of subjects: 81
Study 35612708 — intervention group
Group type: COMPARATOR
Intervention: Finerenone 10 mg with Maalox
Number of subjects: 81
Study 34002953 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with pioglitazone plus exenatide or insulin
Number of subjects: 38
Study 34002953 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with homeostasis model assessment of IR <1.9
Number of subjects: 38
Study 34002953 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with homeostasis model assessment of IR ≥1.9
Number of subjects: 38
Study 32044174 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically used bilayer collagen membrane with fibrin glue (Chondro‐Gide)
Number of subjects: 11
Study 32044174 — intervention group
Group type: COMPARATOR
Intervention: Trilayer collagen prototype without fibrin glue
Number of subjects: 11
Study 36315955 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity statin + ezetimibe
Number of subjects: 0
Study 36315955 — intervention group
Group type: COMPARATOR
Intervention: High-intensity statin alone
Number of subjects: 0
Study 33091455 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical endodontic treatment (NSET)
Number of subjects: 60
Study 33091455 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical endodontic treatment (NSET) combined with vital pulp therapy (VPT)
Number of subjects: 60
Study 33091455 — intervention group
Group type: COMPARATOR
Intervention: NSET and VPT
Number of subjects: 60
Study 32563188 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual trigger (GnRH agonist and hCG)
Number of subjects: 155
Study 32563188 — intervention group
Group type: COMPARATOR
Intervention: hCG trigger
Number of subjects: 155
Study 35555189 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine Nitrate (CN: 5 g/day + 0.675 g/day of maltodextrin)
Number of subjects: 12
Study 35555189 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF: 400 mg/day + 5 g/day of maltodextrin)
Number of subjects: 12
Study 35555189 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine Nitrate + Caffeine (CN+CAF: 5 g/day of creatine nitrate + 400 mg/day of caffeine)
Number of subjects: 12
Study 35555189 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL: 5.4 g/day of maltodextrin)
Number of subjects: 12
Study 37723993 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sildenafil citrate, administered after onset of labor
Number of subjects: 0
Study 37723993 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 33248439 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol energy gel (0.5% concentration)
Number of subjects: 40
Study 33248439 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol energy gel (0.1% concentration)
Number of subjects: 40
Study 33248439 — intervention group
Group type: COMPARATOR
Intervention: Mint-flavored placebo (CON)
Number of subjects: 40
Study 33172865 — intervention group
Group type: EXPERIMENTAL
Intervention: Teprotumumab treatment for 24 weeks
Number of subjects: 6
Study 33172865 — intervention group
Group type: COMPARATOR
Intervention: Non-TED control group
Number of subjects: 6
Study 32989632 — intervention group
Group type: EXPERIMENTAL
Intervention: Free Androgen Index (FAI)
Number of subjects: 1000
Study 32989632 — intervention group
Group type: EXPERIMENTAL
Intervention: Free Testosterone (FT)
Number of subjects: 1000
Study 32989632 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Testosterone (TT)
Number of subjects: 1000
Study 36437811 — intervention group
Group type: EXPERIMENTAL
Intervention: Test yoghurt (Lactiplantibacillus plantarum Inducia)
Number of subjects: 240
Study 34929814 — intervention group
Group type: EXPERIMENTAL
Intervention: Moringa oleifera leaf capsules
Number of subjects: 75
Study 34929814 — intervention group
Group type: COMPARATOR
Intervention: TTD capsules
Number of subjects: 75
Study 32745733 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR) with SAPIEN 3 or SAPIEN 3 Ultra device
Number of subjects: 440
Study 32745733 — intervention group
Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 440
Study 32745733 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 440
Study 32745733 — intervention group
Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 440
Study 35546289 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Care Pathway (ICP)
Number of subjects: 28
Study 35546289 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 28
Study 35546289 — intervention group
Group type: COMPARATOR
Intervention: Control group without dementia (n = 17)
Number of subjects: 28
Study 35546289 — intervention group
Group type: COMPARATOR
Intervention: Control group without dementia (n = 36)
Number of subjects: 28
Study 34088340 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of NSAIDs
Number of subjects: 605
Study 34088340 — intervention group
Group type: EXPERIMENTAL
Intervention: Not meeting physical activity guidelines
Number of subjects: 605
Study 32741328 — intervention group
Group type: EXPERIMENTAL
Intervention: SAPP plus perturbation training (n = 19)
Number of subjects: 39
Study 32741328 — intervention group
Group type: COMPARATOR
Intervention: SAPP (n = 20)
Number of subjects: 39
Study 35915452 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-of-care methods in addition to rapid molecular testing using the BioFire® FilmArray® Pneumonia Panel plus (FAP plus)
Number of subjects: 0
Study 35915452 — intervention group
Group type: COMPARATOR
Intervention: Standard microbiological testing (control group)
Number of subjects: 0
Study 32907566 — intervention group
Group type: EXPERIMENTAL
Intervention: Navafenterol 400 μg
Number of subjects: 38
Study 32907566 — intervention group
Group type: EXPERIMENTAL
Intervention: Navafenterol 1800 μg
Number of subjects: 38
Study 32907566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 32907566 — intervention group
Group type: COMPARATOR
Intervention: Indacaterol 150 μg
Number of subjects: 38
Study 32907566 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium 18 μg
Number of subjects: 38
Study 35514033 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms for predicting lung cancer-specific survival (LCSS) and overall survival (OS) in the training cohort.
Number of subjects: 9584
Study 35514033 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms for predicting LCSS and OS in elderly patients with metastatic NSCLC.
Number of subjects: 9584
Study 35514033 — intervention group
Group type: COMPARATOR
Intervention: Nomograms for predicting LCSS and OS compared to TNM staging models.
Number of subjects: 9584
Study 34111867 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Number of subjects: 18
Study 36343472 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated virtual reality therapy (gameChange)
Number of subjects: 345
Study 36343472 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 345
Study 32001075 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) applied to bilateral deltoid and quadriceps femoris muscles with 50 Hz for 3 days/week, 8 weeks
Number of subjects: 0
Study 32001075 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 0
Study 34621143 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D laparoscopy
Number of subjects: 158
Study 33164850 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise before exposure for 20 min (Before Only, BO)
Number of subjects: 0
Study 33164850 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise after exposure for 20 min (After Only, AO)
Number of subjects: 0
Study 33164850 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise before and after exposure for 10 min at each time (Before and After, BA)
Number of subjects: 0
Study 33164850 — intervention group
Group type: COMPARATOR
Intervention: No-exercise Control (NC)
Number of subjects: 0
Study 33164850 — intervention group
Group type: COMPARATOR
Intervention: Comparison of BA condition to NC condition in Study Two
Number of subjects: 0
Study 35647942 — intervention group
Group type: EXPERIMENTAL
Intervention: IHMs plus any one of the following MTs: Cephalandra indica, Gymnema sylvestre, and Syzygium jambolanum (experimental)
Number of subjects: 89
Study 35647942 — intervention group
Group type: COMPARATOR
Intervention: IHMs only (control)
Number of subjects: 89
Study 33231847 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy group intervention (8 sessions)
Number of subjects: 76
Study 32731748 — intervention group
Group type: EXPERIMENTAL
Intervention: NDBI-Fi measure
Number of subjects: 0
Study 36093920 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab adjunct to sertraline
Number of subjects: 36
Study 36093920 — intervention group
Group type: COMPARATOR
Intervention: Placebo adjunct to sertraline
Number of subjects: 36
Study 32030691 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Perspective Questionnaire (PPQ)
Number of subjects: 350
Study 34893436 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial scratching (scratch group)
Number of subjects: 117
Study 34893436 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure (sham group)
Number of subjects: 117
Study 36214182 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention via videoconference (n=25)
Number of subjects: 50
Study 36214182 — intervention group
Group type: COMPARATOR
Intervention: Unguided training via podcasts (n=25)
Number of subjects: 50
Study 34162962 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light exposure (2500 lx)
Number of subjects: 21
Study 34162962 — intervention group
Group type: COMPARATOR
Intervention: Dim light exposure (<50 lx)
Number of subjects: 21
Study 32360313 — intervention group
Group type: EXPERIMENTAL
Intervention: NACP on the base formulation (with 20 wt.% NACP)
Number of subjects: 4
Study 32360313 — intervention group
Group type: EXPERIMENTAL
Intervention: NACP on the antibacterial formulation (with 20 wt.% NACP and 5 wt.% DMAHDM)
Number of subjects: 4
Study 32360313 — intervention group
Group type: COMPARATOR
Intervention: Base formulation (without NACP and DMAHDM)
Number of subjects: 4
Study 32360313 — intervention group
Group type: COMPARATOR
Intervention: Negative control (without sealant application)
Number of subjects: 4
Study 35438671 — intervention group
Group type: EXPERIMENTAL
Intervention: NLTX (50 mg)
Number of subjects: 14
Study 35438671 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 14
Study 36394651 — intervention group
Group type: EXPERIMENTAL
Intervention: Low concentration of lidocaine (group B)
Number of subjects: 48
Study 36394651 — intervention group
Group type: EXPERIMENTAL
Intervention: High concentration of lidocaine (group C)
Number of subjects: 48
Study 36394651 — intervention group
Group type: COMPARATOR
Intervention: Control group (group A)
Number of subjects: 48
Study 34398009 — intervention group
Group type: EXPERIMENTAL
Intervention: Rational emotive occupational health coaching (12 sessions)
Number of subjects: 158
Study 32926825 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 0
Study 32926825 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor
Number of subjects: 0
Study 35676589 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in ventricular size (VS)
Number of subjects: 248
Study 35676589 — intervention group
Group type: COMPARATOR
Intervention: Measures of perihematomal edema (PHE)
Number of subjects: 248
Study 33758322 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based pain management application
Number of subjects: 128
Study 33758322 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education provided)
Number of subjects: 128
Study 34631134 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with smartphone app-based lifestyle intervention and conventional outpatient weight-management visits every 3 months
Number of subjects: 28
Study 34631134 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving only weight-management visits
Number of subjects: 28
Study 34631134 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 28
Study 35048226 — intervention group
Group type: EXPERIMENTAL
Intervention: 2L PEG + Ascorbic Acid
Number of subjects: 347
Study 35048226 — intervention group
Group type: COMPARATOR
Intervention: 4L PEG
Number of subjects: 347
Study 35101326 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0
Study 35101326 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 0
Study 34218768 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led systematic medication review
Number of subjects: 0
Study 34218768 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pharmacist recommendations)
Number of subjects: 0
Study 32017816 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG Biofeedback therapy
Number of subjects: 0
Study 34016485 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded aerobic exercise (GAEx)
Number of subjects: 36
Study 34016485 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard rehabilitation only)
Number of subjects: 36
Study 34686621 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive stereotype
Number of subjects: 45
Study 34686621 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative stereotype
Number of subjects: 45
Study 34686621 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study 36334689 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile web-based educational program (2-week duration)
Number of subjects: 73
Study 36334689 — intervention group
Group type: COMPARATOR
Intervention: Educational booklet
Number of subjects: 73
Study 32796054 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised decision‐support software
Number of subjects: 46042
Study 35708562 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation and Deep Breathing Exercises
Number of subjects: 116
Study 35708562 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 116
Study 34923994 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant (80 mg daily)
Number of subjects: 80
Study 34923994 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyzine (25 mg daily)
Number of subjects: 80
Study 36055414 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg caffeinated drink (CAF)
Number of subjects: 25
Study 36055414 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 25
Study 33446924 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum (n = 32)
Number of subjects: 80
Study 33446924 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 48)
Number of subjects: 80
Study 34477122 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard lymphadenectomy (SG)
Number of subjects: 212
Study 34477122 — intervention group
Group type: COMPARATOR
Intervention: Extended lymphadenectomy (EG)
Number of subjects: 212
Study 34477122 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard lymphadenectomy with postoperative adjuvant chemotherapy (SG)
Number of subjects: 212
Study 34477122 — intervention group
Group type: COMPARATOR
Intervention: Extended lymphadenectomy with postoperative adjuvant chemotherapy (EG)
Number of subjects: 212
Study 34509972 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation sessions (15 sessions of 40 minutes each)
Number of subjects: 55
Study 35999684 — intervention group
Group type: EXPERIMENTAL
Intervention: 38 percent silver diamine fluoride (SDF)
Number of subjects: 80
Study 35999684 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTIVA™
Number of subjects: 80
Study 35999684 — intervention group
Group type: EXPERIMENTAL
Intervention: Beautifil®
Number of subjects: 80
Study 35999684 — intervention group
Group type: COMPARATOR
Intervention: Equia Forte®
Number of subjects: 80
Study 35999684 — intervention group
Group type: COMPARATOR
Intervention: Conditioner application
Number of subjects: 80
Study 32395094 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish version of the Cultural Competence Assessment Instrument
Number of subjects: 312
Study 33463088 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic obeticholic acid (10 mg)
Number of subjects: 0
Study 33463088 — intervention group
Group type: COMPARATOR
Intervention: Branded obeticholic acid (Ocaliva)
Number of subjects: 0
Study 33463088 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting conditions
Number of subjects: 0
Study 33463088 — intervention group
Group type: EXPERIMENTAL
Intervention: Fed conditions
Number of subjects: 0
Study 33463088 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 0
Study 33463088 — intervention group
Group type: COMPARATOR
Intervention: Men
Number of subjects: 0
Study 32573860 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrahydrocurcumin (THC) 40 mg/kg for 3 days
Number of subjects: 0
Study 35968504 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented prostheses
Number of subjects: 60
Study 35968504 — intervention group
Group type: COMPARATOR
Intervention: Biologic prostheses
Number of subjects: 60
Study 32141126 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble dietary fiber (SDF) 20-g/d polydextrose
Number of subjects: 49
Study 32141126 — intervention group
Group type: COMPARATOR
Intervention: Control group (same EN solution without SDF)
Number of subjects: 49
Study 32141126 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble dietary fiber (SDF)
Number of subjects: 49
Study 36308982 — intervention group
Group type: EXPERIMENTAL
Intervention: NMR platform
Number of subjects: 1100
Study 36308982 — intervention group
Group type: EXPERIMENTAL
Intervention: LC-MS platform
Number of subjects: 1100
Study 35222874 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided 18G-PTC puncture needle therapy
Number of subjects: 68
Study 35222874 — intervention group
Group type: COMPARATOR
Intervention: Small needle-knife therapy
Number of subjects: 68
Study 34488841 — intervention group
Group type: EXPERIMENTAL
Intervention: Early administration of colchicine
Number of subjects: 0
Study 34488841 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32842965 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia Care Mapping (DCM) intervention
Number of subjects: 48
Study 32842965 — intervention group
Group type: EXPERIMENTAL
Intervention: Managerial support and leadership approaches
Number of subjects: 48
Study 32842965 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding and engagement with the intervention
Number of subjects: 48
Study 36942113 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunica Albuginea Urethroplasty (Group A)
Number of subjects: 30
Study 36942113 — intervention group
Group type: COMPARATOR
Intervention: Buccal Mucosa Graft Urethroplasty (Group B)
Number of subjects: 30
Study 36942113 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 34986487 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-Based Cognitive Rehabilitation (CBCR) intervention group 1
Number of subjects: 30
Study 34986487 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-Based Cognitive Rehabilitation (CBCR) intervention group 2
Number of subjects: 30
Study 34986487 — intervention group
Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 30